✦ LIBER ✦

A Three-Outcome Design for Phase II Clinical Trials

✍ Scribed by Daniel J. Sargent; Victor Chan; Richard M. Goldberg

Book ID: 114186800
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 140 KB
Volume: 22
Category: Article
ISSN: 0197-2456
DOI: 10.1016/s0197-2456(00)00115-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal three-stage designs for phase II

Optimal three-stage designs for phase II cancer clinical trials

✍ T. Timothy Chen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

The objective of a phase II cancer clinical trial is to screen a treatment that can produce a similar or better response rate compared to the current treatment results. This screening is usually carried out in two stages as proposed by Simon. For ineffective treatment, the trial should terminate at

Decision Theoretic Designs for Phase II

Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes

✍ Nigel Stallard; Peter F. Thall; John Whitehead 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 812 KB

A predictive probability design for phas

A predictive probability design for phase II cancer clinical trials

✍ Lee, J J.; Liu, D. D 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 957 KB

Optimal and minimax three-stage designs

Optimal and minimax three-stage designs for phase II oncology clinical trials

✍ Kun Chen; Michael Shan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Balanced two-stage designs for phase II

Balanced two-stage designs for phase II clinical trials

✍ Fei Ye, ; Shyr, Y. 📂 Article 📅 2007 🏛 SAGE Publications 🌐 English ⚖ 156 KB

Optimal two-stage designs for phase II c

Optimal two-stage designs for phase II clinical trials

✍ Richard Simon 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 594 KB